That's a good addition fuzzyjr. The other good thing that I liked about having Ms. Simone on board is the likely great connections in the biotech industry. If things do go sideways the fund is going to want to recapture as much of there capital as possible and she is conected enough to get financing to pursue any promising indications.
tada